对国家药品监督管理局公布的复方丹参片质量抽检不合格问题的分析和建议
({{custom_author.role_cn}}), {{javascript:window.custom_author_cn_index++;}}Data Analysis and Suggestions on Unqualified Compound Danshen Tablets from Drug Sampling based on NMPA Drug Quality Announcement
({{custom_author.role_en}}), {{javascript:window.custom_author_en_index++;}}| {{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
| 〈 |
|
〉 |
